EXOSX
Price
$36.62
Change
+$0.14 (+0.38%)
Updated
Oct 17 closing price
Net Assets
347.18M
RERAX
Price
$60.79
Change
-$0.26 (-0.43%)
Updated
Oct 17 closing price
Net Assets
137.72B
Interact to see
Advertisement

EXOSX vs RERAX

Header iconEXOSX vs RERAX Comparison
Open Charts EXOSX vs RERAXBanner chart's image
Manning & Napier Overseas Series I
Price$36.62
Change+$0.14 (+0.38%)
VolumeN/A
Net Assets347.18M
American Funds EUPAC R1
Price$60.79
Change-$0.26 (-0.43%)
VolumeN/A
Net Assets137.72B
EXOSX vs RERAX Comparison Chart in %
View a ticker or compare two or three
VS
EXOSX vs. RERAX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EXOSX is a Hold and RERAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERAX has more cash in the bank: 138B vs. EXOSX (347M). EXOSX pays higher dividends than RERAX: EXOSX (1.13) vs RERAX (0.22). EXOSX was incepted earlier than RERAX: EXOSX (23 years) vs RERAX (23 years). RERAX (1.57) is less costly to investors than EXOSX (0.79). EXOSX is a more actively managed with annual turnover of: 57.00 vs. RERAX (35.00). RERAX has a lower initial minimum investment than EXOSX: RERAX (250) vs EXOSX (1000000). RERAX annual gain was more profitable for investors over the last year : 9.84 vs. EXOSX (7.93). EXOSX return over 5 years is better than : 35.78 vs. RERAX (9.42).
EXOSXRERAXEXOSX / RERAX
Total Expense Ratio0.761.5748%
Annual Report Gross Expense Ratio0.791.5750%
Fund Existence23 years23 years-
Gain YTD14.11720.54369%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets347M138B0%
Annual Yield % from dividends1.130.22508%
Returns for 1 year7.939.8481%
Returns for 3 years55.6345.45122%
Returns for 5 years35.789.42380%
Returns for 10 years100.1735.44283%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HALO67.030.15
+0.22%
Halozyme Therapeutics
TECTP10.82-0.03
-0.28%
Tectonic Financial
NTWK4.50-0.02
-0.44%
NetSol Technologies
GPCR27.38-0.18
-0.65%
Structure Therapeutics
RXT1.42-0.05
-3.40%
Rackspace Technology